CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published ahead of print on December 28, 2005
Clin J Am Soc Nephrol 1: 263-268, 2006
© 2006 American Society of Nephrology
doi: 10.2215/CJN.00990905
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.00990905v1
1/2/263    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGowan, T. A.
Right arrow Articles by Sharma, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGowan, T. A.
Right arrow Articles by Sharma, K.

Diabetes and the Kidney

Stimulation of Urinary TGF-ß and Isoprostanes in Response to Hyperglycemia in Humans

Tracy A. McGowan*, Stephen R. Dunn{dagger}, Bonita Falkner{ddagger}, and Kumar Sharma*,{dagger}

* Center for Diabetic Kidney Disease, {dagger} Cell and Molecular Biology of Kidney Disease-Dorrance Hamilton Research Laboratories, and {ddagger} Center for Hypertension, Division of Nephrology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania

Address correspondence to: Dr. Kumar Sharma, Thomas Jefferson University, Department of Medicine, 353 Jefferson Alumni Hall, 1020 Locust Street, Philadelphia, PA 19107. Phone: 215-503-6950; Fax: 215-923-7212; E-mail: kumar.sharma{at}jefferson.edu

TGF-ß and oxidant stress have been considered to play key roles in the pathogenesis of diabetic vascular complications; however, the stimulus for these factors in humans is not clear. The purpose of this in vivo study was to determine whether transient hyperglycemia in humans is sufficient to increase renal production of TGF-ß1 and urinary isoprostanes in normal humans. A hyperglycemic clamp procedure was performed on 13 healthy volunteers. An infusion of glucose was delivered to maintain the plasma glucose between 200 and 250 mg/dl for 120 min. Timed urine samples, collected on an overnight period before the study, at each void on completion of the procedure, and the following overnight, were assayed for TGF-ß1, F2-isoprostanes, and creatinine. Plasma samples were assayed for TGF-ß1 before and at timed intervals throughout hyperglycemia. Mean baseline TGF-ß1 in plasma was 4.57 ± 0.22 ng/ml, and no change in plasma TGF-ß1 levels was detected throughout the hyperglycemia period. Baseline urine TGF-ß1 was 4.14 ± 1.16 pg/mg creatinine. The fractional urine samples showed a sharp increase in TGF-ß1 excretion in the 12-h period after exposure to hyperglycemia, with a mean peak TGF-ß1 of 30.43 ± 8.05 pg/mg (P = 0.002). TGF-ß1 excretion in the subsequent overnight urine sample was not different from baseline (4.62 ± 1.21 pg/mg). Urinary isoprostanes increased from a baseline of 4.92 ± 0.74 to 13.8 ± 3.37 ng/mg creatinine. It is concluded that 120 min of hyperglycemia in normal humans is sufficient to induce an increase in renal TGF-ß1 and isoprostane production.




This article has been cited by other articles:


Home page
 JCOHome page
Q. Dai, Y.-T. Gao, X.-O. Shu, G. Yang, G. Milne, Q. Cai, W. Wen, N. Rothman, H. Cai, H. Li, et al.
Oxidative Stress, Obesity, and Breast Cancer Risk: Results From the Shanghai Women's Health Study
J. Clin. Oncol., May 20, 2009; 27(15): 2482 - 2488.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society of Nephrology.